C103H146N24O8S4 — CID 160621916
1-[4-[4-(3-butan-2-yl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-[4-[4-(3-cyclohexyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;molecular hydrogen (PubChem CID 160621916) has the molecular formula C103H146N24O8S4 and a molecular weight of 1976.73 g/mol. Its IUPAC name is 1-[4-[4-(3-butan-2-yl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-[4-[4-(3-cyclohexyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;molecular hydrogen.
| Compound Name | 1-[4-[4-(3-butan-2-yl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-[4-[4-(3-cyclohexyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;molecular hydrogen |
|---|---|
| PubChem CID | 160621916 |
| Molecular Formula | C103H146N24O8S4 |
| Molecular Weight | 1976.73 g/mol |
| Exact Mass | 1975.06 |
| IUPAC Name | 1-[4-[4-(3-butan-2-yl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-[4-[4-(3-cyclohexyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;1-cyclopropyl-2-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]ethanone;1-[4-[4-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]butan-2-one;molecular hydrogen |
| SMILES | CCC(=O)Cc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CC(O)(C(C)CC)C3)n2)cc1.CCC(=O)Cc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CC(O)(C4CCCCC4)C3)n2)cc1.CCC(=O)Cc1ccc(Sc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CC(O)(C4CC4)C3)n2)cc1.Cc1cc(Nc2cc(N3CC(O)(C4CC4)C3)nc(Sc3ccc(CC(=O)C4CC4)cc3)n2)n[nH]1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C27H34N6O2S.C26H30N6O2S.C25H28N6O2S.C25H32N6O2S.11H2/c1-3-21(34)14-19-9-11-22(12-10-19)36-26-29-23(28-24-13-18(2)31-32-24)15-25(30-26)33-16-27(35,17-33)20-7-5-4-6-8-20;1-2-19(33)11-16-3-9-20(10-4-16)35-25-28-22(27-23-12-21(30-31-23)17-5-6-17)13-24(29-25)32-14-26(34,15-32)18-7-8-18;1-15-10-22(30-29-15)26-21-12-23(31-13-25(33,14-31)18-6-7-18)28-24(27-21)34-19-8-2-16(3-9-19)11-20(32)17-4-5-17;1-5-16(3)25(33)14-31(15-25)23-13-21(26-22-11-17(4)29-30-22)27-24(28-23)34-20-9-7-18(8-10-20)12-19(32)6-2;;;;;;;;;;;/h9-13,15,20,35H,3-8,14,16-17H2,1-2H3,(H2,28,29,30,31,32);3-4,9-10,12-13,17-18,34H,2,5-8,11,14-15H2,1H3,(H2,27,28,29,30,31);2-3,8-10,12,17-18,33H,4-7,11,13-14H2,1H3,(H2,26,27,28,29,30);7-11,13,16,33H,5-6,12,14-15H2,1-4H3,(H2,26,27,28,29,30);11*1H |
| InChIKey | RGUSJTICVAWCOM-UHFFFAOYSA-N |
| XLogP | 20.62 |
| TPSA | 428.12 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 139 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1976.73 |
| LogP ≤ 5 | 20.62 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 32 |